Suppression of Behçet's disease with dapsone.
Seven male patients with Behçet's disease were treated with dapsone 100 mg daily. All had suppression of their pathergic reaction to a deep needle-prick, with noticeable symptomatic improvement.
D000328:Adult; D001528:Behcet Syndrome / Q000188:drug therapy*; D003622:Dapsone / Q000627:therapeutic use*; D006801:Humans; D008297:Male
D003622:Dapsone